Search results
Homepage | Pfizer Singapore. Science Contact Us. Breakthroughs that Change Patients' Lives Pfizer Colleagues Work to Challenge the Mos t Feared Diseases of Our Time Learn More Coronavirus Resources Current information on our scientific progress Learn More Innovative Therapies for Tomorrow Translating advanced science and technologies into ...
At Pfizer, we’re driven to discover the cure - driven to significantly improve the lives of everyone, everywhere. If you’re similarly driven, you’ll find there’s no better place to begin (and continue) your career than at Pfizer.
Scientific and Laboratory Services (SLS) Singapore supports PGS by providing reference standards to Pfizer’s global network and our partners. We procure, establish, maintain and distribute reference standards required for release, stability and QC testing for more than 1,000 small molecules and focus on materials which are not commercially ...
We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our portfolio of medicines for therapeutic areas include vaccines, oncology, cardiovascular diseases, infectious diseases, immunological disorders, rare diseases and mental health.
Thank you for your interest in Pfizer Singapore. General Enquiry (Non-Medical and Non-Product Related): Tel: +65 64038888 Fax: +65 64038868 Medical Enquiry: Submit your enquiry here or visit our Medical Information Website at: www.pfizermedicalinformation.com.sg
Home News Biopharma Leaders Unite to Stand with Science Learn More Pfizer & BioNTech to Supply Singapore with Vaccine Candidate to Combat COVID-19 Learn More Pfizer Invests $120mil in Biotech Innovation Learn More Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027 Learn More Agreement Reached with Covax for ...
Pfizer is working toward a future where disease doesn’t win, but science does. A future where we do more than treat diseases, we cure them. Every day, Pfizer’s colleagues come to work with the drive and determination to make this vision for the future a reality.
Dec 30, 2020 · The Pfizer-BioNTech COVID-19 vaccine has been reviewed and endorsed for use in Singapore for individuals aged 16 and above. [Updated 3 Feb 2021] The Moderna COVID-19 vaccine has been authorised for use in Singapore. Details here.
Dec 14, 2020 · HSA Grants Interim Authorisation for First COVID-19 Vaccine in Singapore. The Health Sciences Authority (HSA) granted an authorisation today under the Pandemic Special Access Route (PSAR) for the Pfizer-BioNTech COVID-19 vaccine to be used in Singapore for the prevention of Coronavirus Disease 2019 (COVID-19) caused by the severe ...
Sep 15, 2023 · The Health Sciences Authority (HSA) has on 12 September 2023 authorised the updated Comirnaty vaccine by Pfizer to be used in Singapore for the prevention of Coronavirus Disease 2019 (COVID-19) in individuals aged 6 months and above.
